Custom longevity treatment
Metformin ER
Description
Takes 2 minutes • No charge unless approved
6 month plan
$30/month
3 month plan
$35/month
Monthly plan
$50/month
What is Metformin ER?
Metformin ER (extended-release) is a prescription medication commonly used to support blood sugar regulation and metabolic function. In compounded form, it's prepared to release slowly over time, helping reduce gastrointestinal side effects that some people experience with immediate-release formulations. Beyond its traditional use, metformin has also been widely studied for its role in metabolic health and aging-related pathways.
What you'll get
Personalized treatment plan designed for you
Convenient access to prescribed medications
Ongoing check-ins with licensed providers
Adjustments tailored to your progress
Discreet, judgment-free care
How to take
- • Take one capsule daily, preferably in the evening with food to help improve absorption and reduce potential stomach upset.
- • The doctor will personalize your instructions to fit your unique needs. Details will be included in your shipment, if prescribed.
- • Always reach out to your provider if you have any concerns or need assistance.
Side effects
- • Our extended-release formula is designed for fewer side effects than most metformin treatments, though some patients may experience mild and temporary side effects such as digestive upset, vitamin B deficiency, and appetite changes. Contact your provider if you notice any side effects that bother you or don't go away.
- • Prescription products require an online consultation to determine if a prescription is appropriate. We include regular follow-ups with your provider to monitor your response.
*For a 6-month plan paid upfront. Actual price depends on the product and subscription plan.
Only available by prescription from provider after virtual consultation. Actual product packaging may appear differently than shown. Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA safety, effectiveness, or manufacturing review. Individual results may vary.
Who it's for
Metformin ER is designed for adults seeking improved metabolic balance, and may be a strong option for those seeking a proactive, longevity-focused approach to health.
Why Metformin ER?
Metformin ER is used to support foundational metabolic processes that affect energy balance, weight regulation, and long-term health.
Better cellular health
Lower inflammation
Supported metabolism
Healthier aging
Taking Metformin ER
How it works
Metformin ER primarily works by improving how the body responds to insulin. Newer research has found that it also influences cellular energy and metabolic pathways, potentially reducing oxidative stress, lowering inflammation, and optimizing how your body uses energy. This kind of cellular upkeep may help slow age-related decline and support long-term health. The extended-release formulation delivers the medication gradually, helping maintain stable levels throughout the day and supporting a smoother, more tolerable experience.
What to expect
Metformin ER is designed to support long-term metabolic maintenance with minimal side effects. Benefits tend to develop gradually over time as metabolic processes adjust. Your provider will guide dosing, monitor response, and make adjustments as needed based on your goals and tolerance. Individual results may vary.
Potential side effects
The most common side effects are usually mild and temporary, including digestive upset, vitamin B deficiency, and appetite changes. Your provider will review your health history and monitor results to help minimize potential risks and ensure the treatment is safe and effective for you.
Aging is personal—your care should be too
Livv providers take a proactive approach to long-term health, aiming to provide care that supports your health today and your goals for the future.
Dr. Gidon Akler, MD
Board-Certified in Medical Genetics & Genomics
Start treatment in 4 easy steps
Intake forms
Answer a few quick questions about your health history and goals.
Doctor review
A licensed provider will determine if the treatment is the right fit for you.
Order processing
The order will be compounded, processed, and shipped, if prescribed.
Free standard shipping
Your treatment will ship quickly and discreetly to your door at no cost.
What our patients are saying
What our patients are saying
Common questions about Metformin ER
Why choose extended-release metformin?
Will Metformin ER help me lose weight?
Can Metformin ER be taken long-term?
Who should not take Metformin ER?
• drink alcohol heavily, which may increase the risk of severe side effects
• have a history of lactic acidosis or metabolic acidosis
• have significantly impaired kidney or liver function
• have conditions that reduce oxygen flow, like severe infections, dehydration, or heart failure
• are pregnant or breastfeeding, unless cleared by your provider
Always discuss your medical history with a provider before starting a new treatment.
How is Metformin ER dosed?
If eligible, how much does this treatment cost?
Your cost depends only on the subscription plan you choose:
- 1-month plan: $55/month
- 3-month plan: $35/month
- 6-month plan: $30/month
Explore more treatments
Need more help?
Get free personalized help from our care team.
Email us at support@joinlivv.com
Or call
(888) 491-1070
Sources
- Blonde L, Dailey GE, Jabbour SA, Reasner CA, Mills DJ. (2004). Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study. Current Medical Research and Opinion, 20(4), 565–572.
- Cheng FF, Liu YL, Du J, Lin JT. (2022). Metformin’s mechanisms in attenuating hallmarks of aging and age-related disease. Aging and Disease, 13(4), 970–986.
- Rena G, Hardie DG, Pearson ER. (2017). The mechanisms of action of metformin. Diabetologia, 60, 1577–1585.
- Seifarth C, Schehler B, Schneider HJ. (2013). Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Experimental and Clinical Endocrinology & Diabetes, 121(1), 27–31.
